← Evidence map

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC.

Naoki Haratake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

33 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37924972